Long non-coding RNA SDPR-AS affects the development of non-small cell lung cancer by regulating SDPR through p38 MAPK/ERK signals

References

• Meaney CL, Zingone A, Brown D, et al. Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma. Oncotarget. 2017;8:40946–40957.
   PubMedGoogle Scholar
• Sève P, Reiman T, Dumontet C. The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancer. Lung Cancer. 2010;67:136–143.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359:1367–1380.
   PubMed Web of Science ®Google Scholar
• Sun M, Liu XH, Lu KH, et al. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Cell Death Dis. 2014;5:e1298–e1298.
   PubMed Web of Science ®Google Scholar
• Thomson CS, Forman D. Cancer survival in England and the influence of early diagnosis: what can we learn from recent EUROCARE results? Br J Cancer. 2009;101:2S102–9.
   Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155
   PubMed Web of Science ®Google Scholar
• Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839:1097–1109.
   PubMed Web of Science ®Google Scholar
• Nie W, Ge H-j, Yang X-q, et al. LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p. Cancer Lett. 2016;371:99–106.
   PubMed Web of Science ®Google Scholar
• Yang Y-R, Zang S-Z, Zhong C-L, et al. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol. 2014;7:6929.
   PubMed Web of Science ®Google Scholar
• Wan L, Sun M, Liu G-J, et al. Long noncoding RNA PVT1 promotes non–small cell lung cancer cell proliferation through epigenetically regulating LATS2 expression. Mol Cancer Ther. 2016;15:1082–1094.
   PubMed Web of Science ®Google Scholar
• Qiu M, Xu Y, Yang X, et al. CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer. Tumor Biol. 2014;35:5375–5380.
   PubMedGoogle Scholar
• Ni W, Song E, Gong M, et al. Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma. Onco Targets Ther. 2017;10:3039–3047.
   PubMed Web of Science ®Google Scholar
• Preker P, Almvig K, Christensen MS, et al. PROMoter uPstream transcripts share characteristics with mRNAs and are produced upstream of all three major types of mammalian promoters. Nucleic Acids Research. 2011;39:7179–7193.
   PubMed Web of Science ®Google Scholar
• Chung LY, Tang SJ, Sun GH, et al. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2. Clin Cancer Res. 2012;18:4037.
   PubMed Web of Science ®Google Scholar
• Chen KH, Weng MS, Lin JK. Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. Biochem Pharmacol. 2007;73:215.
   PubMed Web of Science ®Google Scholar
• Kleihues P, Cavenee W. World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. Lyon: IARC; 2000.
   Google Scholar
• Yang J, Lin J, Liu T, et al. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes. Lung Cancer. 2014;85:110–115.
   PubMed Web of Science ®Google Scholar
• Hu X, Bao J, Wang Z, et al. The plasma lncRNA acting as fingerprint in non-small-cell lung cancer. Tumour Biol. 2016;37:3497–3504.
   PubMedGoogle Scholar
• Nie F-q, Sun M, Yang J-s, et al. Long noncoding RNA ANRIL promotes non–small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther. 2015;14:268–277.
   PubMed Web of Science ®Google Scholar
• Lu K-h, Li W, Liu X-h, et al. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression. BMC Cancer. 2013;13:461.
   PubMed Web of Science ®Google Scholar
• Shi X, Sun M, Liu H, et al. A critical role for the long non‐coding RNA GAS5 in proliferation and apoptosis in non‐small‐cell lung cancer. Mol Carcinog. 2015;54:E1.
   PubMed Web of Science ®Google Scholar
• Li X, Jia Z, Shen Y, et al. Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate. Cancer Sci. 2008;99:1326–1333.
   PubMed Web of Science ®Google Scholar
• Unozawa M, Kasamatsu A, Higo M, et al. Cavin‐2 in oral cancer: a potential predictor for tumor progression. Mol Carcinog. 2016;55:1037–1047.
   PubMed Web of Science ®Google Scholar
• Ozturk S, Papageorgis P, Wong CK, et al. SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis. Proc Natl Acad Sci USA. 2016;113:638–643.
   PubMed Web of Science ®Google Scholar
• Jing W, Luo P, Zhu M, et al. Prognostic and diagnostic significance of SDPR-Cavin-2 in hepatocellular carcinoma. Cell Physiol Biochem. 2016;39:950–960.
   PubMedGoogle Scholar
• Sun Y, Liu W-Z, Liu T, et al. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct. 2015;35:600–604.
   PubMed Web of Science ®Google Scholar
• Guan C, Lou Y, Zhao K. Express of ERK/p38MAPK protein in lung cancer cell migration and invasion induced by chemokine CCL22. Zhejiang Med J. 2014;
   Google Scholar
• Li C, Fan S, Owonikoko T, et al. Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway. Oncogene. 2011;30(35):3802–3812.
   Web of Science ®Google Scholar
• Tan C, Qian X, Jia R, et al. Matrine induction of reactive oxygen species activates p38 leading to caspase-dependent cell apoptosis in non-small cell lung cancer cells. Oncol Rep. 2013;30:2529–2535.
   PubMed Web of Science ®Google Scholar